Advances in gastrointestinal disorders associated with non-steroidal antiinflammatory agents and aspirin

Gastroenterología y hepatología
Angel Lanas

Abstract

Patients with gastrointestinal (GI) risk factors who require non-steroidal antiinflammatory drugs (NSAIDs) or aspirin must receive gastropreventive therapies. According to some recent surveys, the low prescription rates of these therapies reported some years ago are progressively improving in several European countries, which should be accompanied by a subsequent decrease in the frequency of hospitalizations due to complications of the upper GI tract, but not of those located in the lower GI tract. The most recent data confirm that celecoxib has a better GI safety profile both in the upper and lower GI tract than traditional NSAIDs. The NSAID most frequently involved in admissions for GI complications is aspirin and consequently at-risk patients receiving this drug should also receive antisecretory agents. Cotherapy consisting of proton pump inhibitors with double antiplatelet therapy is highly frequent in Spain, which has been associated with a low incidence of upper GI bleeding, and a growing incidence of patients with lower GI bleeding usually due to pre-existing vascular lesions. Another therapeutic tool that has been proposed to reduce the occurrence of upper GI bleeding in patients taking aspirin is Helicobacter pylori er...Continue Reading

References

Oct 9, 2004·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Nov 8, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jay L GoldsteinDenise T Kruzikas

❮ Previous
Next ❯

Citations

Mar 24, 2016·International Journal of Clinical Pharmacy·Sabrina MontagnaniCorrado Blandizzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Angel Lanas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Maryam DerogarOmid Sadr-Azodi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Francis K L Chan
© 2022 Meta ULC. All rights reserved